(6bR,10aS)-3-Methyl-2,3,6b,7,8,9,10,10a-octahydro-1H-pyrido[3',4':4,5]pyrrolo[1,2,3-de]quinoxaline, 97.0%, 250mg

2-(Pyridin-4-yloxy)acetic acid, 95.0%, 1g

tert-Butyl 2-oxo-7-azaspiro[3.5]nonane-7-carboxylate, 95.0%, 5g

Bis(2,4-dimethoxyphenyl)(2-methoxyphenyl)methanol, 95%, 250mg

5-Ethyl-4-hydroxy-2-methylfuran-3(2H)-one, 95.0%, 5g

2-(3,5-Dimethylphenyl)piperidine, 95%, 1g

4,4''-Di(1H-1,2,4-triazol-1-yl)-1,1':4',1''-terphenyl, 98%, 1g

Copper foil (OFHC), annealed 99.99% 1.0 x 50 x 50 mm 1 pc

7H-PURINE-7-ACETAMIDE, 1,2,3,6-TETRAHYDRO-1,3-DIMETHYL-2,6-DIOXO-N-(6-PHENYL-3-PYRIDAZINYL)-, 98%, 25mg

tert-Butyl 5-Iodopyridin-2-ylcarbamate, 97.0%, 5g

1,3-Diethylbenzene>97.0%(GC)25mL

5-methyl-1H-pyrazol-4-amine hydrochloride, 95+%, 5g

tert-butyl 4-(4-((8-ethyl-7-oxo-7,8-dihydropyrido[2,3-d]pyrimidin-2-yl)amino)-2-fluorophenyl)piperazine-1-carboxylate, 98%, 250mg